![Krysta Davies Foss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 1 202 $ as of 29/06/2026
Krysta Davies Foss is currently the Chief Executive Officer at Triad Strategic Services.
Formerly, Ms. Foss was a Director at XORTX Therapeutics, Inc. from 2025 to 2026.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/03/2026 | 554 ( 0.03% ) | 1 202 $ | 29/06/2026 |
| Companies | Position | Start |
|---|---|---|
Triad Strategic Services | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| XORTX THERAPEUTICS INC. | Director/Board Member | 23/03/2026 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
XORTX Therapeutics, Inc.
 XORTX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Triad Strategic Services |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
